{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:01:48Z","timestamp":1772136108749,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T00:00:00Z","timestamp":1625616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T00:00:00Z","timestamp":1625616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI17C2412"],"award-info":[{"award-number":["HI17C2412"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"crossref","award":["2021R1C1C1005746"],"award-info":[{"award-number":["2021R1C1C1005746"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ototoxic medications can lead to significant morbidity. Thus, pre-marketing clinical trials have assessed new drugs that have ototoxic potential. Nevertheless, several ototoxic side effects of drugs may remain undetected. Hence, we sought to retrospectively investigate the potential risk of ototoxic adverse drug reactions among commonly used drugs via a longitudinal cohort study. An electronic health records-based data analysis with a propensity-matched comparator group was carried out. This study was conducted using the MetaNurse algorithm for standard nursing statements on electronic healthcare records and the National Sample Cohort obtained from the South Korea National Health Insurance Service. Five target drugs capable of causing ototoxic adverse drug reactions were identified using MetaNurse; two drugs were excluded after database-based analysis because of the absence of bilateral hearing loss events in patients. Survival analysis, log-rank test, and Cox proportional hazards regression models were used to calculate the incidence, survival rate, and hazard ratio of bilateral hearing loss among patients who were prescribed candidate ototoxic drugs. The adjusted hazard ratio of bilateral hearing loss was 1.31 (1.03\u20131.68), 2.20 (1.05\u20134.60), and 2.26 (1.18\u20134.33) in cimetidine, hydroxyzine, and sucralfate users, respectively. Our results indicated that hydroxyzine and sucralfate may cause ototoxic adverse drug reactions in patients. Thus, clinicians should consider avoiding co-administration of these drugs with other well-confirmed ototoxic drugs should be emphasized.<\/jats:p>","DOI":"10.1038\/s41598-021-93522-z","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T06:04:51Z","timestamp":1625637891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Detection of unknown ototoxic adverse drug reactions: an electronic healthcare record-based longitudinal nationwide cohort analysis"],"prefix":"10.1038","volume":"11","author":[{"given":"Suehyun","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaehun","family":"Cha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Yeup","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gil Myeong","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,7]]},"reference":[{"issue":"3","key":"93522_CR1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1517\/14740338.5.3.383","volume":"5","author":"JG Yorgason","year":"2006","unstructured":"Yorgason, J. G., Fayad, J. N. & Kalinec, F. Understanding drug ototoxicity: Molecular insights for prevention and clinical management. Expert Opin. Drug Saf. 5(3), 383\u2013399. https:\/\/doi.org\/10.1517\/14740338.5.3.383 (2006) (Pubmed:16610968).","journal-title":"Expert Opin. Drug Saf."},{"key":"93522_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.1999.tb00277.x","volume":"884","author":"E Arslan","year":"1999","unstructured":"Arslan, E., Orzan, E. & Santarelli, R. Global problem of drug-induced hearing loss. Ann. NY Acad. Sci. 884, 1\u201314. https:\/\/doi.org\/10.1111\/j.1749-6632.1999.tb00277.x (1999) (Pubmed:10842579).","journal-title":"Ann. NY Acad. Sci."},{"issue":"4","key":"93522_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.21053\/ceo.2020.01606","volume":"13","author":"DY Oh","year":"2020","unstructured":"Oh, D. Y. & Choi, B. Y. Genetic information and precision medicine in hearing loss. Clin. Exp. Otorhinolaryngol. 13(4), 315\u2013317. https:\/\/doi.org\/10.21053\/ceo.2020.01606 (2020) (Pubmed:33176397).","journal-title":"Clin. Exp. Otorhinolaryngol."},{"issue":"4","key":"93522_CR4","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/cpt.603","volume":"101","author":"C Lanvers-Kaminsky","year":"2017","unstructured":"Lanvers-Kaminsky, C., Zehnhoff-Dinnesen, A. A., Parfitt, R. & Ciarimboli, G. Drug-induced ototoxicity: Mechanisms, pharmacogenetics, and protective strategies. Clin. Pharmacol. Ther. 101(4), 491\u2013500. https:\/\/doi.org\/10.1002\/cpt.603 (2017) (Pubmed:28002638).","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"93522_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.7874\/jao.2017.00360","volume":"22","author":"P Ganesan","year":"2018","unstructured":"Ganesan, P. et al. Ototoxicity: A challenge in diagnosis and treatment. J. Audiol. Otol. 22(2), 59\u201368. https:\/\/doi.org\/10.7874\/jao.2017.00360 (2018) (Pubmed:29471610).","journal-title":"J. Audiol. Otol."},{"issue":"1","key":"93522_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.21053\/ceo.2019.00283","volume":"13","author":"\u0130 Kuzucu","year":"2020","unstructured":"Kuzucu, \u0130 et al. A prognostic marker in idiopathic sudden sensorineural hearing loss: Serum calprotectin. Clin. Exp. Otorhinolaryngol. 13(1), 36\u201340. https:\/\/doi.org\/10.21053\/ceo.2019.00283 (2020) (Pubmed:31344766).","journal-title":"Clin. Exp. Otorhinolaryngol."},{"issue":"4","key":"93522_CR7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.21053\/ceo.2018.01298","volume":"12","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. Response of glucocorticoid receptor alpha and histone deacetylase 2 to glucocorticoid treatment predicts the prognosis of sudden sensorineural hearing loss. Clin. Exp. Otorhinolaryngol. 12(4), 367\u2013375. https:\/\/doi.org\/10.21053\/ceo.2018.01298 (2019) (Pubmed:30993958).","journal-title":"Clin. Exp. Otorhinolaryngol."},{"issue":"5","key":"93522_CR8","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s40264-017-0629-8","volume":"41","author":"KCM Campbell","year":"2018","unstructured":"Campbell, K. C. M. & Le Prell, C. G. Drug-induced ototoxicity: Diagnosis and monitoring. Drug Saf. 41(5), 451\u2013464. https:\/\/doi.org\/10.1007\/s40264-017-0629-8 (2018) (Pubmed:29404977).","journal-title":"Drug Saf."},{"issue":"8","key":"93522_CR9","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.2105\/AJPH.2007.124537","volume":"98","author":"JA Berlin","year":"2008","unstructured":"Berlin, J. A., Glasser, S. C. & Ellenberg, S. S. Adverse event detection in drug development: Recommendations and obligations beyond phase 3. Am. J. Public Health 98(8), 1366\u20131371. https:\/\/doi.org\/10.2105\/AJPH.2007.124537 (2008) (Pubmed:18556607).","journal-title":"Am. J. Public Health"},{"issue":"11","key":"93522_CR10","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1002\/ar.22578","volume":"295","author":"J Schacht","year":"2012","unstructured":"Schacht, J., Talaska, A. E. & Rybak, L. P. Cisplatin and aminoglycoside antibiotics: Hearing loss and its prevention. Anat. Rec. Hoboken 295(11), 1837\u20131850. https:\/\/doi.org\/10.1002\/ar.22578 (2012) (Pubmed:23045231).","journal-title":"Anat. Rec. Hoboken"},{"issue":"1","key":"93522_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000088850","volume":"11","author":"J Schacht","year":"2006","unstructured":"Schacht, J. & Hawkins, J. E. Sketches of otohistory. Part 11: Ototoxicity: Drug-induced hearing loss. Audiol. Neurootol. 11(1), 1\u20136. https:\/\/doi.org\/10.1159\/000088850 (2006) (Pubmed:16219991).","journal-title":"Audiol. Neurootol."},{"issue":"6","key":"93522_CR12","first-page":"601","volume":"15","author":"G Cianfrone","year":"2011","unstructured":"Cianfrone, G. et al. Pharmacological drugs inducing ototoxicity, vestibular symptoms and tinnitus: A reasoned and updated guide. Eur. Rev. Med. Pharmacol. Sci. 15(6), 601\u2013636 (2011) (Pubmed:21796866).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"4","key":"93522_CR13","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1093\/jamia\/ocw168","volume":"24","author":"S Lee","year":"2017","unstructured":"Lee, S. et al. Standard-based comprehensive detection of adverse drug reaction signals from nursing statements and laboratory results in electronic health records. J. Am. Med. Inform. Assoc. 24(4), 697\u2013708. https:\/\/doi.org\/10.1093\/jamia\/ocw168 (2017) (Pubmed:28087585).","journal-title":"J. Am. Med. Inform. Assoc."},{"issue":"2","key":"93522_CR14","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jaip.2019.09.001","volume":"8","author":"JY Kim","year":"2020","unstructured":"Kim, J. Y. et al. Relationship of chronic rhinosinusitis with asthma, myocardial infarction, stroke, anxiety, and depression. J. Allergy Clin. Immunol. Pract. 8(2), 721-727.e3. https:\/\/doi.org\/10.1016\/j.jaip.2019.09.001 (2020) (Pubmed:31541771).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"6","key":"93522_CR15","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/jamaoto.2020.0526","volume":"146","author":"JY Kim","year":"2020","unstructured":"Kim, J. Y., Kim, Y. S., Ko, I. & Kim, D. K. Association between burning mouth syndrome and the development of depression, anxiety, dementia, and Parkinson disease. JAMA Otolaryngol. Head Neck Surg. 146(6), 561\u2013569. https:\/\/doi.org\/10.1001\/jamaoto.2020.0526 (2020) (Pubmed:32352482).","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"93522_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2019.2435","author":"JY Kim","year":"2019","unstructured":"Kim, J. Y., Ko, I. & Kim, D. K. Association of obstructive sleep apnea with the risk of affective disorders. JAMA Otolaryngol. Head Neck Surg. https:\/\/doi.org\/10.1001\/jamaoto.2019.2435 (2019) (Pubmed:31513273).","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"issue":"4","key":"93522_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1001\/jamaoto.2018.4103","volume":"145","author":"JY Kim","year":"2019","unstructured":"Kim, J. Y. et al. Association of chronic rhinosinusitis with depression and anxiety in a nationwide insurance population. JAMA Otolaryngol. Head Neck Surg. 145(4), 313\u2013319. https:\/\/doi.org\/10.1001\/jamaoto.2018.4103 (2019) (Pubmed:30730537).","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"issue":"3","key":"93522_CR18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/00003446-199406000-00004","volume":"15","author":"SA Fausti","year":"1994","unstructured":"Fausti, S. A. et al. High-frequency audiometric monitoring strategies for early detection of ototoxicity. Ear Hear. 15(3), 232\u2013239. https:\/\/doi.org\/10.1097\/00003446-199406000-00004 (1994) (Pubmed:8076721).","journal-title":"Ear Hear."},{"issue":"6","key":"93522_CR19","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/archotol.1993.01880180081015","volume":"119","author":"SA Fausti","year":"1993","unstructured":"Fausti, S. A. et al. High-frequency monitoring for early detection of cisplatin ototoxicity. Arch. Otolaryngol. Head Neck Surg. 119(6), 661\u2013666. https:\/\/doi.org\/10.1001\/archotol.1993.01880180081015 (1993) (Pubmed:8499098).","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"issue":"6","key":"93522_CR20","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.bjorl.2015.08.011","volume":"81","author":"LB Geyer","year":"2015","unstructured":"Geyer, L. B., MennaBarreto, S. S., Weigert, L. L. & Teixeira, A. R. High frequency hearing thresholds and product distortion otoacoustic emissions in cystic fibrosis patients. Braz. J. Otorhinolaryngol. 81(6), 589\u2013597. https:\/\/doi.org\/10.1016\/j.bjorl.2015.08.011 (2015) (Pubmed:26480907).","journal-title":"Braz. J. Otorhinolaryngol."},{"issue":"5","key":"93522_CR21","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s40264-018-0767-7","volume":"42","author":"S Lee","year":"2019","unstructured":"Lee, S. et al. Development of a controlled vocabulary-based adverse drug reaction signal dictionary for multicenter electronic health record-based pharmacovigilance. Drug Saf. 42(5), 657\u2013670. https:\/\/doi.org\/10.1007\/s40264-018-0767-7 (2019) (Pubmed:30649749).","journal-title":"Drug Saf."},{"issue":"3","key":"93522_CR22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/clpt.2011.248","volume":"91","author":"D Yoon","year":"2012","unstructured":"Yoon, D. et al. Detection of adverse drug reaction signals using an electronic health records database: Comparison of the Laboratory Extreme Abnormality Ratio (CLEAR) algorithm. Clin. Pharmacol. Ther. 91(3), 467\u2013474. https:\/\/doi.org\/10.1038\/clpt.2011.248 (2012) (Pubmed:22237257).","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"93522_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1586\/17512433.2015.992878","volume":"8","author":"VK Patadia","year":"2015","unstructured":"Patadia, V. K. et al. Using real-world healthcare data for pharmacovigilance signal detection\u2014The experience of the EU-ADR project. Expert Rev. Clin. Pharmacol. 8(1), 95\u2013102. https:\/\/doi.org\/10.1586\/17512433.2015.992878 (2015) (Pubmed:25487079).","journal-title":"Expert Rev. Clin. Pharmacol."},{"issue":"8","key":"93522_CR24","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/pds.753","volume":"11","author":"M B\u00e4ckstr\u00f6m","year":"2002","unstructured":"B\u00e4ckstr\u00f6m, M., Mj\u00f6rndal, T. & Dahlqvist, R. Spontaneous reporting of adverse drug reactions by nurses. Pharmacoepidemiol. Drug Saf. 11(8), 647\u2013650. https:\/\/doi.org\/10.1002\/pds.753 (2002) (Pubmed:12512239).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"6","key":"93522_CR25","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1046\/j.1365-2125.2003.01903.x","volume":"56","author":"SS Ranganathan","year":"2003","unstructured":"Ranganathan, S. S., Houghton, J. E., Davies, D. P. & Routledge, P. A. The involvement of nurses in reporting suspected adverse drug reactions: Experience with the meningococcal vaccination scheme. Br. J. Clin. Pharmacol. 56(6), 658\u2013663. https:\/\/doi.org\/10.1046\/j.1365-2125.2003.01903.x (2003) (Pubmed:14616426).","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"93522_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/NXN.0b013e318270106e","volume":"31","author":"HJ Ahn","year":"2013","unstructured":"Ahn, H. J. & Park, H. A. Adverse-drug-event surveillance using narrative nursing records in electronic nursing records. Comput. Inform. Nurs. 31(1), 45\u201351. https:\/\/doi.org\/10.1097\/NXN.0b013e318270106e (2013) (Pubmed:23114393).","journal-title":"Comput. Inform. Nurs."},{"issue":"6","key":"93522_CR27","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/pds.3225","volume":"21","author":"A Conforti","year":"2012","unstructured":"Conforti, A. et al. Adverse drug reaction reporting by nurses: Analysis of Italian pharmacovigilance database. Pharmacoepidemiol. Drug Saf. 21(6), 597\u2013602. https:\/\/doi.org\/10.1002\/pds.3225 (2012) (Pubmed:22337264).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"12","key":"93522_CR28","doi-asserted-by":"publisher","first-page":"CD006815","DOI":"10.1002\/14651858.CD006815.pub2","volume":"12","author":"G Guaiana","year":"2010","unstructured":"Guaiana, G., Barbui, C. & Cipriani, A. Hydroxyzine for generalised anxiety disorder. Cochrane Database Syst. Rev. 12(12), CD006815. https:\/\/doi.org\/10.1002\/14651858.CD006815.pub2 (2010) (Pubmed:21154375).","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"93522_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/ebmh.6.3.91","volume":"6","author":"S Akhondzadeh","year":"2003","unstructured":"Akhondzadeh, S. Hydroxyzine may be safe and effective in generalised anxiety disorder. Evid. Based Ment. Health 6(3), 91. https:\/\/doi.org\/10.1136\/ebmh.6.3.91 (2003) (Pubmed:12893802).","journal-title":"Evid. Based Ment. Health"},{"issue":"Suppl 9","key":"93522_CR30","first-page":"63","volume":"31","author":"A Terano","year":"1996","unstructured":"Terano, A., Shimada, T. & Hiraishi, H. Sucralfate and Helicobacter pylori. J. Gastroenterol. 31(Suppl 9), 63\u201365 (1996) (Pubmed:8959523).","journal-title":"J. Gastroenterol."},{"issue":"9","key":"93522_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016640","volume":"7","author":"SC Seong","year":"2017","unstructured":"Seong, S. C. et al. Cohort profile: The National Health Insurance Service-National Health Screening Cohort (NHIS-Heals) in Korea. BMJ Open 7(9), e016640. https:\/\/doi.org\/10.1136\/bmjopen-2017-016640 (2017) (Pubmed:28947447).","journal-title":"BMJ Open"},{"issue":"2","key":"93522_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv319","volume":"46","author":"J Lee","year":"2017","unstructured":"Lee, J., Lee, J. S., Park, S. H., Shin, S. A. & Kim, K. Cohort profile: The National Health Insurance Service-national sample cohort (NHIS-NSC), South Korea. Int. J. Epidemiol. 46(2), e15. https:\/\/doi.org\/10.1093\/ije\/dyv319 (2017) (Pubmed:26822938).","journal-title":"Int. J. Epidemiol."},{"issue":"7","key":"93522_CR33","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7150\/ijms.6048","volume":"10","author":"T Sakaeda","year":"2013","unstructured":"Sakaeda, T., Tamon, A., Kadoyama, K. & Okuno, Y. Data mining of the public version of the FDA Adverse Event Reporting System. Int. J. Med. Sci. 10(7), 796\u2013803. https:\/\/doi.org\/10.7150\/ijms.6048 (2013) (Pubmed:23794943).","journal-title":"Int. J. Med. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-93522-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-93522-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-93522-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T06:19:29Z","timestamp":1670048369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-93522-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,7]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["93522"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-93522-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-153821\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,7]]},"assertion":[{"value":"23 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14045"}}